Aayush Agrawal, a promoter of Ajanta Pharma Limited, has announced the release of 9,76,000 equity shares from pledge. Concurrently, 9,20,000 equity shares have been pledged. The release is attributed to loan repayment, while the new pledge serves as additional security. These actions impact the promoter’s pledged shareholding and reflect ongoing financial management by the promoter group.
Promoter Share Movement Disclosure
Aayush Agrawal, acting as the promoter of Ajanta Pharma Limited, has officially disclosed significant transactions concerning pledged shares. In an announcement dated August 27, 2026, Agrawal stated the release of 9,76,000 equity shares from existing pledges. This move is part of a broader financial strategy involving loan repayments.
New Pledge Created for Security
In conjunction with the release, a new pledge has been established on 9,20,000 equity shares of Ajanta Pharma. This action is stated to be for the purpose of providing additional security. The details of these shareholding changes have been formally submitted to the stock exchanges as per regulatory requirements.
Regulatory Filing
The disclosure is made in compliance with Regulation 31(1) and 31(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Enclosed with this announcement is the prescribed form detailing the release and creation of the pledge on Ajanta Pharma Limited shares. The company’s scrip codes are BSE – AJANTPHARM 532331 and NSE – AJANTPHARM EQ.
Source: BSE
